← Back to headlines
Insiders Sell Shares in Ultra Clean and Corcept
Insiders at Ultra Clean Holdings and Corcept Therapeutics have sold shares. The sales occurred after Ultra Clean reported Q1 revenue of $533.7 million and Corcept received FDA approval, leading to a $1.05 billion outlook.
12 Jul, 21:15 — 12 Jul, 21:15
Sources
Showing 1 of 1 sources
Related Stories
Homeland Security Secretary’s Plane Makes Emergency Landing After Engine Failure
31m ago
Berkshire Hathaway Signals Long-Term Commitment to Japanese Trading Houses
40m ago
South Korean Utility Proposes $15 Billion Upfront Power Payment From Samsung
1h ago
Chevron Confirms Expansion of Oil Operations in Venezuela
1h ago